US Patent Issued to Beijing Youcare Kechuang Pharmaceutical Technology on Sept. 22 for "Long-acting spleen-targeting cationic lipid compound comprising benzene ring structure, composition comprising same, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,930, issued on Sept. 22, was assigned to Beijing Youcare Kechuang Pharmaceutical Technology Co. Ltd. (Beijing).

"Long-acting spleen-targeting cationic lipid compound comprising benzene ring structure, composition comprising same, and use thereof" was invented by Gengshen Song (Beijing), Honglei Zhang (Beijing), Yuqing Ma (Beijing), Lijie Jin (Beijing) and Jing Li (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to the field of medicine, specifically to a long-acting spleen-targeting cationic lipid compound comprising a benzene ring structure, a composition comprising the same, and a use thereof. More specifical...